Hunan China Sun Pharmaceutical Machinery Co., Ltd (SZSE:300216) signed a stake transfer agreement to acquire additional 41.96% stake in Hunan Chinasun Chronic Disease Health Management Co., Ltd from CDB Development Fund Ltd. from CNY 74.2 million on May 18, 2018. Hunan Chinasun Chronic Disease is a subsidiary of Hunan China Sun Pharmaceutical, prior to the deal. Hunan China Sun Pharmaceutical Machinery Co., Ltd (SZSE:300216) cancelled the acquisition of additional 41.96% stake in Hunan Chinasun Chronic Disease Health Management Co., Ltd from CDB Development Fund Ltd. on May 18, 2019.